Fact Check: Birth Control Pill Use Does NOT Guarantee Cancer Diagnosis, But Does Have Risks

Fact Check

  • by: Jennifer Dobner
Fact Check: Birth Control Pill Use Does NOT Guarantee Cancer Diagnosis, But Does Have Risks Pill ≠ Cancer

Does use of birth control pills, classified by international cancer researchers as a Class 1 carcinogen, mean that a woman will develop cancer? No, that's not true: Decades of research show that oral contraceptives do not significantly increase the likelihood that women will develop certain cancers. The pills can, in fact, reduce the likelihood of other cancers.

The claim about birth control pills appeared in an October 4, 2022, slideshow on Instagram. This fact check addresses only the first photo in that slideshow.


The slideshow's caption opened:

The modern world is a scam. The birth control. The food. The water. The clothes. The dopamine. The jobs. The researchers. The materialism. The casual sex. The 'experts'.

This is why everyone is so lost and confused.

We've been completely misled. Nothing can be trusted today.

Here's how the slideshow image looked at the time of writing:

Screen Shot 2022-10-05 at 11.30.58 AM.png

(Source: Screenshot of Instagram post taken Wed Oct 5 2022 at 11:50:30 UTC)

The post is misleading and lacks context because it fails to say that more than two decades of research show that birth control use has both benefits and risks for women -- a fact acknowledged by the very organization the slideshow names, the International Agency for Research on Cancer (IARC), an arm of the World Health Organization.

Furthermore, the post implies that using oral contraceptives will result in a cancer diagnosis. That's not true. Researchers have identified carcinogenic properties in dozens of other commonly used items such as alcohol, household cleaners and tobacco, as well as from a person's exposure to the sun, but those carcinogenic properties do not necessarily result in a cancer diagnosis.

As the American Cancer Society notes on its website, "carcinogens do not cause cancer at all times, under all circumstances."

According to the National Cancer Institute, the female hormones estrogen and progesterone, in their natural state, can stimulate the growth of some cancers. Synthetic versions of the hormones, which are used to make birth control pills, have that same potential and can increase the risk of some cancers, including breast and cervical cancers.

The IARC has been providing lists of the carcinogenic risks of chemicals since 1971. An advisory committee of experts reviews scientific research to evaluate the strength of the evidence for the environmental factors or other agents that may present hazards. An explanation of how the evidence is evaluated can be found on the IARC website.

Experts classify the potential risks on a scale of 1 to 3 -- from the most carcinogenic to chemicals that cannot be classified as carcinogenic. IARC has labeled 122 agents as Class 1, including combined oral contraceptives, which are the most commonly used form of birth control and contain both estrogen and progesterone.

The IARC does place estrogen-progesterone oral contraceptives in the Class 1 category of risk. Its entry, however, has a notation that "there is also convincing evidence in humans that these agents confer a protective effect against cancer in the endometrium and ovary."

The entry can be seen here:

Screen Shot 2022-10-05 at 11.43.12 AM.png

(Source: IARC webpage taken Wed Oct 5, 2022 at 11:43:12 UTC)

As early as the 1980s, researchers investigating the relationship between the birth control pill and cancer in American women have found its use did not significantly increase the risk of breast cancer.

In fact, the National Cancer Institute's Cancer and Steroid Hormone Study found that oral contraceptives appear to decrease the risk of developing ovarian and endometrial cancer. A variety of factors, such as the age of a woman, the number of years on birth control and the type of contraceptive used, can alter the level of risk, however.

Such findings have been repeatedly confirmed over some two decades by researchers around the world, including in Canada, Sweden, Denmark and the United Kingdom. A catalog of research papers, some of which address specific types of cancer, can be found within the archives of the National Cancer Institute and the National Library of Medicine.

This is how the National Cancer Institute summarized these studies in a fact sheet on oral contraceptives and cancer risk:

Overall ... these studies have provided consistent evidence that the risks of breast and cervical cancers are increased in women who use oral contraceptives, whereas the risks of endometrial, ovarian, and colorectal cancers are reduced.

Additional Lead Stories fact checks of claims related to cancer can be found here.

Want to inform others about the accuracy of this story?

See who is sharing it (it might even be your friends...) and leave the link in the comments.:

  Jennifer Dobner

Jennifer Dobner is a Salt Lake City-based journalist with more than two decades of reporting experience. Jennifer has worked as a staffer for The Associated Press, The Salt Lake Tribune, San Diego Union-Tribune and Idaho Falls Post-Register. As a freelancer her work has been published by The New York Times, Outside Magazine Online, Reuters, Cannabis Wire and others. Jennifer’s documentary film work includes the international award-winning 2018 film Church & State and 2021’s award-winning Anchor Point.

Read more about or contact Jennifer Dobner

About Us

International Fact-Checking Organization Meta Third-Party Fact Checker

Lead Stories is a fact checking website that is always looking for the latest false, misleading, deceptive or inaccurate stories, videos or images going viral on the internet.
Spotted something? Let us know!.

Lead Stories is a:


Subscribe to our newsletter

* indicates required

Please select all the ways you would like to hear from Lead Stories LLC:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

Most Read

Most Recent

Share your opinion